Articles From: kaleo announces $150 million debt financing to support commercialization of EVZIO™ to Kalpataru Goes Live With Oracle HCM Cloud to Support Rapid Talent Management


2014/4/7
RICHMOND, Va.
Sign-up for kaleo announces $150 million debt financing to support commercialization of EVZIO™ investment picks
2014/3/26
Kalimantan Gold Corporation Limited (the "Company") is pleased to announce that the Indonesian Ministry of Forestry has granted PT Jelai Cahaya Minerals an extension to its Borrow and Use Exploration Forestry Permit (IPPKH) for its 100% owned Jelai Gold project in north eastern Kalimantan.
Sign-up for Kalimantan Gold - Jelai Gold Project investment picks
Kalimantan Gold Corporation Limited (TSX-V:KLG) (LSE:KLG) is pleased to announce the latest drill and assay results from holes drilled at the Beruang Kanan, Mamuring, Low Zone and Bukit Dea projects together with the commencement of an airborne magnetic and gravity gradiometer survey.
Sign-up for Kalimantan Gold - KSK Copper Project Update investment picks
2013/10/8
Kalimantan Gold Corporation Limited (the "Company" or “KLG”) announces that Doris Meyer has notified the Company of her decision to retire as Chief Financial Officer with effect from October 1, 2013.
Sign-up for Kalimantan Gold Appoints New CFO investment picks
2013/12/10
As a result of a review of the technical disclosure of Kalimantan Gold Corporation Limited (the “Company”) (TSX-V:KLG) by the British Columbia Securities Commission, the Company is issuing this press release to clarify certain of its recently published technical disclosure on the Company’s website at www.kalimantan.com and in material distributed through press releases in relation to a technical report filed on November 27, 2013.
Sign-up for Kalimantan Gold Clarifies Previous Disclosure Following a Preliminary Technical Disclosure Review By BCSC investment picks
Kalimantan Gold Corporation Limited ("KLG" or the “Company”) is pleased to announce the filing of a NI43-101 Technical Report which confirms the potential for a gold mineral resource to be defined and ultimately developed at KLG’s 100% held Jelai Gold Project (“Jelai” or the “Project”) in North Kalimantan, Indonesia.
Sign-up for Kalimantan Gold Files NI43-101 Report for Jelai Project investment picks
Kalimantan Gold Corporation Limited (the “Company”) (TSX-V:KLG) (AIM:KLG) has been delivered notice of intention to cease sole funding and to withdraw from the joint venture agreement made April 18, 2011 by its joint venture partner, Surya Kencana LLC, a wholly owned subsidiary of Freeport-McMoRan Exploration Corporation (“Freeport”), in relation to the Company’s KSK Contract of Work copper project (the “KSK CoW”) in Kalimantan, Indonesia.
Sign-up for Kalimantan Gold to Regain 100% Control of KSK CoW, Indonesia investment picks
2014/3/13
SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios Announces Fiscal Year 2013 Financial Results investment picks
2013/12/10
- Data Presented as Poster at American Society of Hematology Annual Meeting and Exhibition SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody investment picks
SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios Announces Retirement Of Chief Financial Officer investment picks
2014/4/3
SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios Announces Upcoming Participation at Needham Healthcare Conference investment picks
2014/3/10
BioCentury Conference Presentation to be Webcast SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios Announces Upcoming Participation at ROTH and BioCentury's Future Leaders in the Biotech Industry Conferences investment picks
2014/2/5
SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios Announces Upcoming Webcasts and Conference Participation investment picks
Lam Joins KaloBios with Over 28 Years Biopharmaceutical Manufacturing Experience SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios Appoints Harry Lam, Ph.D. as Head of Manufacturing investment picks
SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios Appoints V. Bryan Lawlis, Jr., Ph.D. to Board of Directors investment picks
SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios Elects Laurie Smaldone Alsup, M.D. to Board investment picks
2014/2/11
-- Study Focused on Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Who are EphA3 Positive --
Sign-up for KaloBios Initiates Phase 2 Expansion Portion of Study of KB004 in Hematologic Malignancies investment picks
2013/10/1
SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares investment picks
2013/9/26
SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios Pharmaceuticals, Inc. Prices Public Offering of Common Stock investment picks
SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios Pharmaceuticals, Inc. Proposes Public Offering of Common Stock investment picks
- KB004, experimental anti-EphA3 monoclonal antibody therapeutic, in clinical development against hematologic cancers SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios Receives Notice of Allowance for Key Composition of Matter Patent Covering KBOO4 investment picks
2013/8/19
SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios Reports Second Quarter 2013 Financial Results investment picks
2013/11/12
SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios Reports Third Quarter 2013 Financial Results investment picks
2014/1/29
Study Does Not Meet Primary Endpoint SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios Reports Top-Line Data for Phase 2 Study of KB003 in Severe Asthma investment picks
SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios to Present at BioCentury's NewsMakers in the Biotech Industry Conference investment picks
SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios to Present at Leerink Swann Rare Disease Roundtable investment picks
2013/9/5
SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios to Present at Stifel Healthcare Conference 2013 investment picks
2013/11/7
SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios to Present KB004 Interim Phase 1 Clinical Data in Hematologic Malignancies at ASH investment picks
Human Safety and PK/PD Data from Phase 1 Study of KB001 Supports Ongoing Phase 2 Clinical Trial of KB001-A in Cystic Fibrosis SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios' KB001 Anti-Pseudomonas Antibody Study Published in Pediatric Pulmonology investment picks
2014/1/22
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1083622&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Kalpataru Goes Live With Oracle HCM Cloud to Support Rapid Talent Management investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: kaleo announces $150 million debt financing to support commercialization of EVZIO™ to Kalpataru Goes Live With Oracle HCM Cloud to Support Rapid Talent Management
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity